Iceland vs Slovakia: Life science patents granted, by technology
Iceland
3 patents
in 2021
Slovakia
3 patents
in 2023
Iceland rank
48th
Slovakia rank
48th
Life science patents granted, by technology over time
- Iceland
- Slovakia
How they compare
Iceland currently reports 3 patents against 3 patents in Slovakia, a difference of 0 patents.
The two have swapped places 5 times across 28 shared years of data; in 1994 it was Iceland ahead.
Iceland ranks 48th and Slovakia ranks 48th of 65 countries.
Slovakia has averaged higher in every one of the 4 decades both report.
Head to head by decade
| Decade | Iceland | Slovakia | Difference | Ahead |
|---|---|---|---|---|
| 1990s | 6.67 patents | 49.5 patents | 42.83 patents | Slovakia |
| 2000s | 30.9 patents | 134.8 patents | 103.9 patents | Slovakia |
| 2010s | 16.8 patents | 29.5 patents | 12.7 patents | Slovakia |
| 2020s | 2.5 patents | 2.5 patents | 0 patents | — |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher life science patents granted, by technology, Iceland or Slovakia?
- Iceland, at 3 patents against 3 patents in Slovakia as of 2021.
- What is the difference in life science patents granted, by technology between Iceland and Slovakia?
- 0 patents, with Iceland ahead.
- How many years of comparable data are there for Iceland and Slovakia?
- 28 years are reported by both, from 1994 to 2021.
- How do Iceland and Slovakia rank globally for life science patents granted, by technology?
- Iceland ranks 48th and Slovakia ranks 48th of 65 countries.
- Where does this data come from?
- World Intellectual Property Organization (WIPO) (2025) – processed by Our World in Data, published as Life science patents granted, by technology. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of pharmaceutical patents granted by the filing office in a given year. Pharmaceutical patents typically cover new drugs, biological treatments or vaccines.